820 related articles for article (PubMed ID: 11483333)
1. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer.
Martinez AA; Yan D; Lockman D; Brabbins D; Kota K; Sharpe M; Jaffray DA; Vicini F; Wong J
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1226-34. PubMed ID: 11483333
[TBL] [Abstract][Full Text] [Related]
2. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer.
Yan D; Lockman D; Brabbins D; Tyburski L; Martinez A
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):289-302. PubMed ID: 10925000
[TBL] [Abstract][Full Text] [Related]
3. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
Ghilezan M; Yan D; Liang J; Jaffray D; Wong J; Martinez A
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1602-10. PubMed ID: 15590192
[TBL] [Abstract][Full Text] [Related]
4. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
[TBL] [Abstract][Full Text] [Related]
5. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
[TBL] [Abstract][Full Text] [Related]
6. Conformal irradiation of concave-shaped PTVs in the treatment of prostate cancer by simple 1D intensity-modulated beams.
Fiorino C; Broggi S; Corletto D; Cattaneo GM; Calandrino R
Radiother Oncol; 2000 Apr; 55(1):49-58. PubMed ID: 10788688
[TBL] [Abstract][Full Text] [Related]
7. Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy.
Reddy NM; Nori D; Chang H; Lange CS; Ravi A
Med Phys; 2010 Jul; 37(7):3791-801. PubMed ID: 20831087
[TBL] [Abstract][Full Text] [Related]
8. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
9. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
10. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
[TBL] [Abstract][Full Text] [Related]
11. Comparison of various online IGRT strategies: The benefits of online treatment plan re-optimization.
Schulze D; Liang J; Yan D; Zhang T
Radiother Oncol; 2009 Mar; 90(3):367-76. PubMed ID: 18976828
[TBL] [Abstract][Full Text] [Related]
12. Complementary Relation Between the Improvement of Dose Delivery Technique and PTV Margin Reduction in Dose-Escalated Radiation Therapy for Prostate Cancer.
Utsunomiya S; Yamamoto J; Tanabe S; Oishi M; Satsuma A; Kaidu M; Abe E; Ohta A; Kushima N; Aoyama H
Pract Radiat Oncol; 2019 May; 9(3):172-178. PubMed ID: 30772440
[TBL] [Abstract][Full Text] [Related]
13. Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer.
Patel RR; Orton N; Tomé WA; Chappell R; Ritter MA
Radiother Oncol; 2003 Jun; 67(3):285-94. PubMed ID: 12865176
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
Kassim I; Dirkx ML; Heijmen BJ
Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric advantages and superior treatment delivery efficiency of RapidArc over conventional intensity-modulated radiotherapy in high-risk prostate cancer involving seminal vesicles and pelvic nodes.
Poon DM; Kam M; Leung CM; Chau R; Wong S; Lee WY; Wong KC; Yu B; Chan A
Clin Oncol (R Coll Radiol); 2013 Dec; 25(12):706-12. PubMed ID: 23954261
[TBL] [Abstract][Full Text] [Related]
16. Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing.
Dogan N; King S; Emami B; Mohideen N; Mirkovic N; Leybovich LB; Sethi A
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1480-91. PubMed ID: 14630288
[TBL] [Abstract][Full Text] [Related]
17. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic IMRT for prostate cancer: dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRT.
Wang L; Movsas B; Jacob R; Fourkal E; Chen L; Price R; Feigenberg S; Konski A; Pollack A; Ma C
J Appl Clin Med Phys; 2004; 5(2):29-41. PubMed ID: 15738911
[TBL] [Abstract][Full Text] [Related]
19. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC
Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467
[No Abstract] [Full Text] [Related]
20. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
